Bio-Path gets Nasdaq extension to Sept 8 to meet $2.5M equity rule

BIO-PATH HOLDINGS, INC.

Non-compliance with Nasdaq minimum stockholders' equity of $2.5M noted March 12, 2024.
Compliance plan submitted April 26, 2024; extension granted June 12, 2024 through Sept 8, 2024.
If not compliant by Sept 8, delisting subject to appeal to Nasdaq Hearings Panel.
Company intends to pursue compliance but no assurance of success or appeal outcome.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.